Fulvestrant 250 mg/5 mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 250 mg/5 mL
Reference Brands: Faslodex (EU & US),Fulzos (India)
Category: Oncology Cancer Care
Fulvestrant is an injectable oncology drug used to treat hormone receptor-positive breast cancer. Available as 250 mg/5 mL IM injection in the US and EU.
Product Description:
Fulvestrant is a potent estrogen receptor antagonist used in the treatment of HR+ metastatic breast cancer in postmenopausal women. It is indicated for patients whose cancer has progressed after prior endocrine therapy. Marketed as Faslodex®, Fulvestrant is available in both the US and EU as a 250 mg/5 mL intramuscular injection, typically administered as 500 mg monthly. It works by binding and degrading estrogen receptors, thereby inhibiting cancer cell growth. Widely used in oncology hospitals and cancer centers, Fulvestrant is a valuable product for B2B pharmaceutical distribution in the oncology and specialty injectable segments.
Fulvestrant — third party manufacturing & bulk supply
Fulvestrant 250 mg/5 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Fulvestrant listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Fulvestrant →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Fulvestrant is used in the treatment of hormone receptor-positive metastatic or locally advanced breast cancer in postmenopausal women. It is commonly used in patients whose cancer has progressed after treatment with other hormonal therapies such as tamoxifen or aromatase inhibitors.
Fulvestrant is a synthetic estrogen receptor antagonist that binds to estrogen receptors and blocks the effects of estrogen on breast cancer cells, helping to slow or stop the growth of hormone-dependent tumors.
The most widely known trade name is Faslodex.
The original brand Faslodex was developed and marketed by AstraZeneca. Many pharmaceutical companies now manufacture generic versions globally.
The generic name is Fulvestrant.
Brand names include Faslodex and several generic branded versions available in different markets.
Fulvestrant injections are manufactured in several countries including the United States, the United Kingdom, India, and other EU pharmaceutical manufacturing hubs depending on the manufacturer.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
